Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.42 (
DTA
)
1,693
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
For the first time, the co-templating ionothermal methodology was used in the preparation of layered aluminophosphate materials. With the addition of either 1,2-ethylenediamine or 1,6-hexanediamine to the ionic liquid 1-ethyl-3-methyl imidazolium chloride, two new 2D layered aluminophosphates
RUB
-A1 [Al(3)P(4)O(16)][NH(3)CH(2)CH(2)NH(3)](0.5)[C(6)N(2)H(11)](2) and
RUB
-A2 [Al(3)P(4)O(16)][NH(3)(CH(2))(6)NH(3)][NH(3)(CH(2))(6)NH(2)](0.5)[C(6)N(2)H(11)](0.5)[H(2)O] have been synthesized ionothermally by co-templating. The structure of
RUB
-A1 has been determined from single-crystal X-ray diffraction data using direct methods, while the structure of
RUB
-A2 has been solved ab initio from powder X-ray diffraction data with limited resolution using direct-space methods. Both of these two compounds have a 2D layered structure consisting of macroanionic sheets of composition [Al(3)P(4)O(16)](3-) stacked in an AAAA sequence. The inorganic layers are built up from alternatively vertex-sharing [AlO(4)]- and [PO(3)(=O)]-tetrahedral units forming a 4.6.8 and a 4.6.12 network for
RUB
-A1 and
RUB
-A2, respectively. The layer topology of
RUB
-A1 is closely related to the previously known 4.6.8-layer topology but with a different sequence of phosphoryl group orientation. Combining the results of structure analysis with the NMR, chemical analysis and TG-
DTA
experiments, we show that both the ionic liquid cation and the protonated diamines are located in the interlayer space and together direct the formation of these two structures.
...
PMID:Co-templating ionothermal synthesis and structure characterization of two new 2D layered aluminophosphates. 2294 Jul 50